Comparison

Eotaxin [42285.111]

Item no. 20-272-190188
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Antibody
Applications WB, ELISA
Clone 42285. 111
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-119268
Similar products 20-272-190188
Available
Genway ID:
GWB-119268
Clone:
42285. 111
Isotype:
IgG2a
Immunogen:
Purified recombinant mouse eotaxin expressed in E. coli.
Antigen Species:
Mouse
Specificity:
This antibody exhibits less than 10 % cross-reactivity with recombinant human eotaxin recombinant mouse MARC and recombinant human 6Ckine.
Target:
Eotaxin
Localization:
Secreted
Concentration:
0. 5 mg/ml
Purification Note:
The antibody is purified from the IgG fraction of the tissue culture supernatant using protein G affinity chromatography. Storage
Preservative:
NoneConstituents: PBS
Application Note:
ELISA: Use at a concentration of 0. 5 - 1 µ g/ml. The detection limit for recombinant mouse eotaxin is approximately 1. 2 ng/well. Neut: Use at a concentration of 10 - 30 µ g/ml. WB: Use at a concentration of 1 - 2 µ g/ml. Predicted
Molecular Weight:
8. 4 kDa. The detection limit for recombinant mouse eotaxin is approximately 20 ng/lane under non-reducing and reducing conditions. Monoclonal Eotaxin has the ability to neutralize the biological activity of recombinant mouse eotaxin. It will also neutralize the biological activity of human eotaxin under similar conditions. To measure this chemoattractant activity recombinant mouse eotaxin is incubated with various concentrations of the antibody for 30 minutes at room temperature in a 96 well microplate. Following this preincubation period 35 µ l of the cytokine-antibody solution (containing recombinant mouse eotaxin at a final concentration of 0. 1 µ g/ml and antibody at concentrations from 0. 01 to 100 µ g/ml) is transferred to the lower compartment of a 96 well chemotaxis chamber. The chemotaxis chamber is then assembled using a PVP-free polycarbonate filter (5 micron pore size) and 2 x 10^6 cells/ well (CCR-3 transfected Y3 rat myeloid cells) are added to the top chamber. After incubation for 3 hours at 37 C in a 5 % CO2 humidified incubator the chamber is disassembled and the cells that have migrated through to the lower chamber are transferred to a working plate and stained using MTT. Absorbance is read on a microplate reader. The exact concentration of antibody required to neutralize recombinant mouse eotaxin activity is dependent on the cytokine concentration cell type growth conditions and the type of activity. The Neutralization Dose50 (ND50) for the antibody is defined as that concentration required to yield one-half maximal inhibition of the eotaxin activity on a responsive cell line when eotaxin is present at a concentration just high enough to elicit a maximum response. The Neutralization Dose50 (ND50) for this antibody is approximately 10 to 30 µ g/ml in the presence of 100 ng/ml of recombinant mouse eotaxin measuring the chemotaxis of CCR-3 transfected rat myeloid Y3 cellsNot tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Secreted Eotaxin a member of the beta (CC) chemokine family of inflammatory and immunoregulatory cytokines was originally purified from bronchoalveolar lavage fluid of guinea pigs sensitized by aerosol challenge with ovalbumin. Eotaxin has been found in three species (human mouse and guinea pig) which share approximately 60 % sequence homology. Mouse eotaxin also shows high sequence identity to the MCP family of cytokines. Mouse eotaxin cDNA encodes a 97 amino acid residue precursor protein from which the amino-terminal 23 amino acid residues are cleaved to generate the 74 amino acid residue mature mouse eotaxin. Mature mouse eotaxin has a predicted molecular mass of approximately 8. 4 kDa. Eotaxin is a potent eosinophil activator and chemoattractor. As an activator eotaxin is a mediator of inflammation by initiating actin polymerization intracellularly and inducing the production of reactive oxygen species. As a chemoattractant both in vivo and in vitro eotaxin exhibits potent activity on eosinophils but not mononuclear cells or neutrophils. Eotaxin has the ability to prime eosinophils for chemotaxis direct their migration and to activate inflammatory activity. Eotaxin mRNA is expressed in a variety of tissues. Its expression is induced in cultured endothelial cells in response to IFN-gamma. Eotaxin mRNA is also induced in response to the transplantation of IL-4- secreting tumor cells. A receptor for human eotaxin has been identified and found to be the third numbered receptor in the C-C chemokine subfamily of receptors (CCR3). The mouse counterpart to human CCR3 has also been isolated. This receptor for mouse eotaxin binds both mouse and human eotaxin with equal affinity.
Function:
In response to the presence of allergens this protein directly promotes the accumulation of eosinophils a prominent feature of allergic inflammatory reactions. Binds to CCR3.
Subcellular Location:
Secreted.
Induction:
By TNF-alpha interleukin-1 alpha and interferon gamma.
Ptm:
O-linked glycan consists of a Gal-GalNAc disaccharide which is mofified with up to 2 sialic acid residues.
Similarity:
Belongs to the intercrine beta (chemokine CC) family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close